# Efficacy and Safety of Remimazolam (CNS7056) Compared to Propofol for Intravenous Anesthesia During Elective Surgery

> **NCT03661489** · PHASE3 · COMPLETED · sponsor: **Paion UK Ltd.** · enrollment: 469 (actual)

## Conditions studied

- Anesthesia, Intravenous

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT03661489
- **Lead sponsor:** Paion UK Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-24
- **Primary completion:** 2020-04-02
- **Final completion:** 2020-04-02
- **Target enrollment:** 469 (ACTUAL)
- **Last updated:** 2020-05-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03661489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03661489, "Efficacy and Safety of Remimazolam (CNS7056) Compared to Propofol for Intravenous Anesthesia During Elective Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03661489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*